Skip to main content
OpenTrials

Clinical trial condition

Waldenstrom Macroglobulinemia

Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.

394 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Waldenstrom Macroglobulinemia trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström Macroglobulinemia

NCT07169331

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Sun Yat Sen University Cancer Center Guangzhou, Guangdong, China
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Affiliated Hospital of Hebei University Baoding, Hebei, China
View Trial Details
Recruiting

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

NCT05602363

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +34 more
Locations
  • UC Irvine Health Orange, California, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

NCT05780034

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View Trial Details

Related conditions